Author

Vida Ravanmehr

Primary ORCID profile (0000-0002-3971-1083 · 7 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Vida RavanmehriD7 papers · The Jackson Laboratory for Genomic Medicine

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ahmed Haouz· 1 shared Ariel Mechaly· 1 shared Ashley Wilson· 1 shared Estela RojasiD· 1 shared Felipe Samaniego· 1 shared Fernando Rodrigues-Lima· 1 shared Haopeng YangiD· 1 shared Jared M. HendersoniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmed Haouz

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 5, 2023

CREBBP lysine acetyltransferase domain mutations create zombie enzymes that alter chromatin loading dynamics and prevent EP300 redundancy

Haopeng Yang, Wenchao Zhang, Vida Ravanmehr…·Michael R. Green

The paper shows that CREBBP mutations disrupt chromatin loading dynamics and EP300 redundancy, creating zombie enzymes that impair enhancer activation in GC B-cells and lymphoma.

DOI 10.1101/2023.09.05.556242

𝕏 PostBluesky